Evidence map›Paper›PMID 15677747›Full record

ArticleGenetics2005

Multiple pathways for suppression of mutants affecting G1-specific transcription in Saccharomyces cerevisiae.

Karin Flick, Curt Wittenberg

Abstract read
In one paragraph

Article in Genetics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Karin FlickDepartment of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
Curt Wittenberg

Funding

REGULATION OF G1-SPECIFIC GENE EXPRESSION IN YEASTR01GM059441 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI WITTENBERG, CURT · 2000 to 2016
$6.9M
ROLE OF CYCLINS IN CONTROL OF THE YEAST CELL CYCLER01GM043487 · NIGMS · SCRIPPS RESEARCH INSTITUTE · PI WITTENBERG, CURT · 1990 to 2005
$2.0M
NIGMS NIH HHS GM-43487NIGMS NIH HHS GM-59441NIGMS NIH HHS R01 GM043487NIGMS NIH HHS R01 GM059441
6 · The paper itself

Abstract

In the budding yeast, Saccharomyces cerevisiae, control of cell proliferation is exerted primarily during G(1) phase. The G(1)-specific transcription of several hundred genes, many with roles in early cell cycle events, requires the transcription factors SBF and MBF, each composed of Swi6 and a DNA-binding protein, Swi4 or Mbp1, respectively. Binding of these factors to promoters is essential but insufficient for robust transcription. Timely transcriptional activation requires Cln3/CDK activity. To identify potential targets for Cln3/CDK, we identified multicopy suppressors of the temperature sensitivity of new conditional alleles of SWI6. A bck2Delta background was used to render SWI6 essential. Seven multicopy suppressors of bck2Delta swi6-ts mutants were identified. Three genes, SWI4, RME1, and CLN2, were identified previously in related screens and shown to activate G(1)-specific expression of genes independent of CLN3 and SWI6. The other four genes, FBA1, RPL40a/UBI1, GIN4, and PAB1, act via apparently unrelated pathways downstream of SBF and MBF. Each depends upon CLN2, but not CLN1, for its suppressing activity. Together with additional characterization these findings indicate that multiple independent pathways are sufficient for proliferation in the absence of G(1)-specific transcriptional activators.

Indexed as

Saccharomyces cerevisiae ProteinsSignal TransductionTranscription, GeneticCell Cycle ProteinsCell ProliferationG1 PhaseMutationSaccharomyces cerevisiaeCell Cycle ProteinsSaccharomyces cerevisiae Proteins

Identifiers

PMID15677747
PMCPMC1448864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.